Proton Therapy Pediatric denied as duplicate or overlapping therapy by Aetna?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Aetna's specific coverage criteria for proton therapy pediatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Aetna angle on Proton Therapy Pediatric
## Why Aetna Denies Pediatric Proton Therapy as Duplicate Therapy
Aetna may issue a duplicate-therapy denial when its reviewers determine that another radiation modality — typically conventional photon-based radiation — is already authorized or has been recommended, and the plan's policy treats proton beam therapy as providing no meaningful clinical advantage over that alternative for the specific diagnosis. In pediatric oncology, this framing is especially common when the plan's clinical policy lists certain tumor types as covered only when proton therapy offers a dosimetric benefit the alternative cannot provide.
## Why This Denial Is Appealable
Pediatric patients are not interchangeable with adults. A child's developing tissues, organs at risk, and long-term survivorship needs can create genuine clinical distinctions between radiation modalities that a blanket duplicate-therapy label ignores. The treating radiation oncologist is best positioned to document precisely why conventional radiation is not a clinically equivalent substitute for this patient, at this age, with this tumor location and proximity to critical structures.
## Federal Appeal Framework
- Internal appeal: Submit a written internal appeal within 180 days of the denial notice. Aetna must issue a decision within the timeframe required by your plan type.
- External review (ACA §2719): If the internal appeal is denied, you are entitled to an independent external review by an accredited Independent Review Organization (IRO). The IRO's decision is binding on the plan.
- ERISA §503 (employer-sponsored plans): Requires a full-and-fair review with access to the plan's criteria and the reviewer's reasoning.
- Expedited review: If waiting for a standard review would seriously jeopardize the patient's life or health — particularly relevant when a treatment window is time-sensitive — request an expedited internal and external review simultaneously.
- External review window: Generally must be initiated within four months of final internal denial.
## Documentation to Gather
- Diagnosis confirmation: Pathology report, imaging, and staging documentation.
- Tumor location and proximity to critical structures: Radiation oncologist's treatment-planning notes explaining organs at risk and why proton therapy's dose distribution is clinically distinct from photon alternatives for this child.
- Prior treatment history: Any prior radiation, chemotherapy, or surgery with dates and outcomes.
- Pediatric-specific clinical severity: Growth plates, neurocognitive structures, cardiac and pulmonary proximity — all documented in the chart.
- Prescriber medical-necessity letter: A detailed letter from the treating radiation oncologist explaining why photon therapy is not a clinical equivalent and why proton therapy is medically necessary for this specific pediatric patient.
- Applicable guideline support: Reference the relevant guideline organization (such as the applicable COG or ASTRO guidance) generically, without citing specific numbers.
## Criteria-Mapping Structure
Obtain Aetna's current published clinical policy for proton beam therapy. Copy each coverage criterion from that policy document. For each criterion, identify the exact corresponding fact in the patient's medical record and cite it by date and author. This side-by-side mapping — policy requirement on the left, chart evidence on the right — is the most effective format for both the internal appeal and the external reviewer. Do not rely on general assertions; every criterion must be answered with a specific documented fact.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →